Measurement of Residual Host Cell Protein and DNA in Biotechnology Products Work Shop

On Monday, June 3rd at 2:35 PM EpiVax’s CEO/CSO Dr. Annie De Groot presented a talk on the Immunogenicity Analysis of CHOP Contaminants in Therapeutic Protein Formulations.

The workshop was hosted by USP and BEBPA, and designed specifically for the biopharmaceutical industry. The meeting will focued on scientific, technical, regulatory, and clinical topics surrounding host cell proteins (HCP) and residual DNA. Case studies were also presented.

Check out our previous post on this topic.  Click here to see our 2012 CHO publication Here.

See Dr. Annie De Groot’s presentation below:

Are you attending this conference?  Would you like to meet?  Contact us!
Anthony Marcello
BDA EpiVax, inc.
Email Us Here.